Thursday, January 31, 2019

Democrats Shouldn’t Abandon Medicare for All Over a Misleading Survey


Appearing in COMMON DREAMS An article by Richard Eskow suggests that it may not have been possible for Kaiser Family Foundation (KFF),  given its internal culture, to conduct an unbiased survey. Eskow writes:

David Leonhardt of the New York Times has highlighted a survey from the Kaiser Family Foundation that, if true, would suggest that Medicare for All is not nearly as popular as initial polling would suggest. Based on this survey’s results, Leonhardt concludes that Democrats who support the idea are committing an “unforced error.”

Unfortunately, that survey is deeply misleading. While pollsters made it clear that they were merely presenting “some arguments some people have made for or against a national Medicare-for-all plan,” they only presented partial arguments in favor of Medicare for All while presenting deeply deceptive arguments against it. Their questions almost certainly skewed the results.

The poll finds that 56 percent of voters surveyed initially support “Medicare for All” and 42 percent oppose it, for a net favorability rating of +14 percent. When arguments in favor of Medicare for All are presented—it will guarantee coverage to all Americans and reduce out-of-pocket costs—net favorability rises to +45 percent. (KFF does not provide the raw numbers here.)

Support reportedly falls dramatically when people hear arguments against the program. The problem, however, is in the presentation.The pros, as presented, are understated. Medicare for All would not “reduce” out-of-pocket costs. It would eliminate them for all medical interventions, including hospitalization, surgery, pharmaceuticals, medical devices, and doctor visits.  The use of “reduce” suggests that any out-of-pocket savings would be marginal at best, which is not true.

The KFF survey told respondents that Medicare for All would “require most Americans to pay more in taxes.” It did tell them that health insurance premiums would be eliminated, but failed to explain that the vast majority of families would pay considerably less in taxes than they currently pay in premiums and out-of-pocket costs. Many working Americans with employer-based insurance are unaware of how much is deducted from their paychecks in premiums, which also dilutes the impact of this question.

The survey told respondents that Medicare for All would “eliminate private health insurance companies,” but it did not tell them why: these corporations add to the overall cost of health care without providing anything of value.

It gets worse. The pollsters then presented the statement that Medicare for All will “threaten the current Medicare program.” While this is a common Republican line of attack, it is an openly deceptive one. Medicare for All proposals would expand and improve coverage for seniors and the disabled under the current program, by expanding the scope of services rendered and eliminating out-of-pocket costs in most cases.

Surveyors also offered the argument that Medicare for All could “lead to delays in people getting some medical tests and treatments.” There is no evidence to support this assertion, and no reason to believe it’s true. The opposite should be the case, in fact. While increased demand could lead to limited delays, the elimination of insurance company bureaucracy, paperwork, network restrictions, and pre-certification procedures means that overall wait times should be reduced.

Despite the survey’s methodological flaws, Leonhardt uses it to conclude that Medicare for All is politically unfeasible. He suggests that Democrats embrace another plan instead: the Center for American Progress proposal (in Leonhardt’s words from an earlier column) “through which any American, regardless of age, could buy health insurance” from the government.

There are serious actuarial problems with this approach, however. As has been seen with Medicare Advantage, the private-insurance option for today’s Medicare, insurance companies are experts at “cherry-picking” healthy enrollees. (As some whistleblower cases demonstrate, they can also be expert at committing fraud.) This would create service problems for enrollees and financial problems for the government.

The immediate questions are these: Why was the KFF survey so flawed, and why has Leonhardt (and presumably others) been so quick to embrace it? Leonhardt describes KFF as “one of the country’s most respected health care pollsters,” and so it has been. But KFF, like other mainstream health institutions, is deeply embedded in the current health care system’s political culture. A centrist Democrat and two former Republican senators sit on its Board of Trustees, one of whom is former Senate majority leader and physician William Frist. Frist is the son of Thomas Frist, founder of Hospital Corporation of America. The Washington Post reported that his HCA holdings represented a “significant source of his wealth” (a reported $13 million in 1994).

Given its internal culture, it may not have been possible for KFF to present the arguments for and against Medicare for All in an unbiased manner.

It’s true that the GOP (and centrist Democrats) will likely present these misleading arguments in much the same way they do. But why should Democrats tailor their platform to voters’ reactions, when those reactions are based on a biased or one-sided set of arguments? An important proposal like Medicare for All should be subjected to public debate, so that the public gets a deeper understanding of its ramifications. That is, after all, why we have elections.

And why would Leonhardt or political scientist Brendan Nyhan (whom he quotes) embrace such a flawed survey instrument so quickly? It may be a simple case of confirmation bias, since the survey appears to support their ideas about Medicare for All. That doesn’t make its findings accurate or meaningful. The nation deserves a meaningful debate about Medicare for All.

This is Dio talking: We won't get that meaningful debate unless we flood our representatives' ears with our demands for A TRUE MEDICARE FOR ALL, WHICH SERVES ALL REGARDLESS OF WEALTH -- AND NOT SOME COCKAMAMIE BUY-IN PROGRAM WHICH REWARDS MAINLY THE INSURANCE COMPANIES.  For too long, our opinions have been warped by corporate propaganda which would have us fear everything but the status quo. If our representatives don't hear the roar of our demand, it will be too easy for them to pretend they're being prudent, while in reality they are simply buying in to the line that brings in the money.

Dio

If you'd like to leave a comment -- and I hope you will -- simply click on the number of comments area, and share your thoughts in the "comment box" that appears. Thanks!

10 comments:

  1. The "POLITICS" of Healthcare is both socially economic and a question of Political Economy itself, and the rhetoric follows the money interests with justice and ideology often at odds with each other, or at least in irreconcilable internal contradictions. If that sounds an unfriendly or even hostile divorce scenario, well...that seems to fit the picture writ large. Here are the divides in an article that attempts to define these irreconcilable differences:
    http://www.businesspundit.com/strongest-arguments-single-payer-health-care-system/
    The 20 Strongest Arguments FOR AND AGAINST A Single Payer Health Care System
    BY Paul Lighter (From "The Business Pundit blog; October 2018).
    "...the United States is the only very highly developed nation without universal health care. That’s over 50 countries of diverse size, values, economic stature, and cultures. And many of these nations have implemented single payer successfully."
    (Having said that...)see the full article.
    The highlights of each of the 20 selected positions are live, and lead to that base argument's
    cited reference material.

    In my opinion it is not enough to be able to justify single payer / Universal Health rights in our political arena as it stands today based entirely on profit driven markets, vested interests and entrenched nested wealth who are driving the power play in the media and with well tuned propaganda tactics over the general public.
    To truly deal with this class sector, each of their own core arguments must be critically dismantled and that means reading them, facing them, understanding them (historically and presently) and then politically dis-arming them...to defeat them. And asking our political representatives to stand alone to do this will not be the winning option, if we don't back them with full support and a winning argument politically. In this case we need to tell the politicians to "follow the money," but we need to tell the super-rich and mega-wealth communities to "swallow the money" and give us our rights to healthcare; NOW!

    The 20 Strongest Arguments For and Against A Single Payer Health Care System

    ReplyDelete
  2. On "Consolidation" and Too Big To Fail Monopolizing (TBTF)impacts the medical economy we ultimately pay for in real time market costs. Take a look at the magnitude of money we are speaking about and how it amplifies the power of corporate interests that "dictate" to healthcare costs and rising expenses (they love to call rising "medical" expenses.
    article:
    Healthcare IT: HEALTHPAYER INTELLIGENCE / Vera Gruessner Editor
    https://healthpayerintelligence.com/features/how-health-insurance-mergers-could-change-the-payer-industry
    How Health Insurance Mergers Could Change the Payer Industry

    "During the summer of 2015, Aetna and Humana, as well as Anthem and Cigna, started a merger process that would reduce four of the nation’s largest insurers down to just two. If the mergers are successful, only three payers would dominate as much as 80 percent of the American marketplace.
    While these large companies believe there are significant advantages to consolidating their efforts, industry stakeholders - and the Department of Justice - have reservations about the deals. The DoJ has filed a lawsuit to stop the mergers, citing antitrust concerns, which the four payers will have to fight in court."
    Department of Justice Moves to Block Health Insurance Mergers
    DOJ Sees Continued Opposition to Health Insurance Mergers
    (THESE MERGERS WERE DEFEATED);

    [but] The health payers’ response to the lawsuit (same article which is still worth reading today)
    illustrates only partially how literally BILLIONS OF DOLLARS are thrown around by these corporations that have nothing to do with medical costs, but everything to do with what is often cited as the rising "costs" [expenses /salaries/ profits]of our medical care system.
    See:https://www.pwc.com/us/en/industries/health-industries/library/behind-the-numbers.html for
    Medical cost trends; inflation and rates of change since 2007.
    -----------
    "But the real standout among rising costs is health care: Between 1960 and 2016, annual U.S. health costs grew about eightfold, accounting for inflation.
    From : (https://mic.com/articles/188498/average-cost-of-living-increase-us-2018-calculator-best-cities-health-care-education#.1mu4ANeaO)
    -------
    Meanwhile
    big Business' wants you to believe (cited over and over again in the media)that:
    'Government policy itself is largely to blame for rising health care costs.'
    and/or that you must take it upon yourself to create a survival plan:
    'With rising healthcare costs it's important to develop a plan that adjusts to the market and your goals. ...' another patterned response from the market gurus on health care advice. (Of course all presuming a middle to upper class ability to plot such a care plan financially).
    --------








    ReplyDelete
  3. Billions are thrown around in the medical market vector capital transactions, where a single year can waste a fortune on schemes to make a fortune even bigger; and in reality--
    'Too big to Scale'

    So now let's consider what the monopolizing attempt cited at the top involved Aetna-Humana $37B health merger, and Cigna-Anthem was a fight over an $48B deal ... and that is $85 billion Dollars being negotiated over what is ultimately the profit potentials of such a consolidation (dressed up, of course, in some formula of market efficiency window dressing). all of which is part of your medical billing and the dark pool of financing that sustains unfair prices (calling it rising costs of care:

    see:https://www.modernhealthcare.com/article/20150811/NEWS/150819988
    How Humana hitched with Aetna (and drove Cigna to Anthem)
    By Bob Herman | August 11, 2015

    "The back story behind Aetna's acquisition of Humana reads like a soap opera in which each of the “big five” health insurance companies were involved and multiple deals were hanging in the air at the same time."
    and:
    "UnitedHealth still lurked in the shadows as Aetna, Anthem, Cigna and Humana juggled multiple balls at once. But Aetna decided to quash any takeover from UnitedHealth during a June 26 board meeting. Aetna and UnitedHealth are both large players in the Medicare Advantage space, and Aetna officials said “that the regulatory and related risks of a potential transaction with Party A were significant” and that UnitedHealth had not addressed the risks “in any credible way.”
    In addition, UnitedHealth had not updated its purchase price for Aetna, which was well below market estimates. Analysts have suggested that UnitedHealth was preoccupied with its $13 billion acquisition of pharmacy benefit manager Catamaran Corp."

    [and among other "expenses" not listed in the deal were the consultants among which were]:
    By December, Humana's board held a meeting and brought in financial adviser Goldman Sachs to discuss potential moves in the industry. The meeting was a precursor to a spate of events that resembled speed dating for health insurers. (See a timeline of the overtures and rejections below.)
    @ the link if you care to follow that timeline as a model of our "Healthcare" expenses
    https://www.modernhealthcare.com/article/20150811/NEWS/150819988

    ReplyDelete
  4. recited from the comment above:
    "But the real standout among rising costs is health care: Between 1960 and 2016, annual U.S. health costs grew about eightfold, accounting for inflation.
    From : (https://mic.com/articles/188498/average-cost-of-living-increase-us-2018-calculator-best-cities-health-care-education#.1mu4ANeaO)
    ----------
    The dates 1960 to 2916 are significant for a special reason that underscores that eight-fold increase in medical costs. These are the precise years that correspond and co-relate to the emergence and intervention of so-called MANAGED CARE; which is touted "Increasingly, in the United States, public and social insurance plans are turning to managed care as a method to control health care expenditure (Journal of Public Health: https://academic.oup.com/jpubhealth/article/19/3/251/1504426)SUMMARY:
    Medical care in the United States continues to consume an increasing amount of the Gross Domestic Product. To control the rising costs of health care many industries have turned to a controlled form of financing and delivery of health care - often referred to as managed care.
    ------
    Managed care is not merely a set of fashionable administrative technologies for controlling the use of medical care and the growth of health care costs; it has become the name for a transformation in the way health care is financed and organized in the United States.
    from: http://www.nyu.edu/projects/rodwin/managedcare.html
    ------------

    "Dr. Paul M. Ellwood, Jr., was the first mainstream political leader to take deliberate steps to change American health care from its longstanding not-for-profit business principles into a for-profit model that would be driven by the insurance industry."

    Often referred to as the "father of the health maintenance organization,"[1][2] he not only coined the term, he also played a role in bringing about structural changes to the American health care system to simultaneously control cost and promote health by replacing fee-for-service with prepaid, comprehensive care"
    Ellwood’s concern about the importance of measuring health outcomes that would hold health providers accountable for quality dated to the mid-1960s. In 1968, as an adviser to the Johnson administration, he devised the plans for the establishment of U.S. Agency for Healthcare Research and Quality (AHRQ). He would become increasingly vocal about the need for evidence-based medicine and outcomes accountability.
    Before healthcare plans emerged, patients would simply pay for services out of pocket.
    While Dr. Paul M. Ellwood, Jr., was both conscientious and a proponent of real comprehensive healthcare;
    "The spread of HMOs and other pre-paid health plans has spawned significant debate about the impact on quality of care"
    https://en.wikipedia.org/wiki/Paul_M._Ellwood_Jr.[and]https://en.wikipedia.org/wiki/Managed_care
    -----
    "Proposed in the 1960s by Dr. Paul Elwood in the "Health Maintenance Strategy", the HMO concept was promoted by the Nixon administration as a fix to rising health care costs and set in law as the Health Maintenance Organization Act of 1973."
    "The backlash included vocal critics, including disgruntled patients and consumer-advocacy groups, who argued that managed care plans were controlling costs by denying medically necessary services to patients, even in life-threatening situations, or by providing low-quality care."
    1990s growth and ubiquity

    By the late 1990s, U.S. per capita healthcare spending began to increase again, peaking around 2002.[9] Despite managed care's mandate to control costs, U.S. healthcare expenditures has continued to outstrip the overall national income, rising about 2.4 percentage points faster than the annual GDP since 1970.[10] https://en.wikipedia.org/wiki/Managed_care

    ReplyDelete
  5. PREDATORS ON THE MARCH: Once an "ART"-then "A SCIENCE...: --It's all just BUSINESS NOW!
    Global Healthcare Private Equity and Corporate M&A Report ...
    www.bain.com/insights/global-healthcare-private-equity-and...
    Bain Capital
    "Powered by rising demand worldwide for medical services, healthcare private equity activity soared in 2017. Powered by rising demand worldwide for medical services, healthcare private equity activity soared in 2017. ... and a still fragmented and largely inefficient delivery system that is ripe for innovation, disruption and consolidation. .."
    --------------
    Private equity gets active in health care industry as docs ...
    www.mibiz.com/item/25453-private-equity-gets-active-in...

    S&P Global Market Intelligence reports 217 private equity investments in health care last year, accounting for 7.2 percent of all deals. That compares with 172 investments five years earlier, or 4.8 percent of all deals.
    --------------------
    BUSINESS CONCERNS: Wall Street investment and "Due Diligence" the major concern at Forbes.
    Ellie Kincaid
    Forbes Staff
    Healthcare
    https://www.forbes.com/healthcare/#591c16343b4e
    Assistant editor covering medicine and health care.
    "Venture capitalists argue that sometimes it is good for a company’s business to publish, but early on in a product’s development it often is not."
    https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020124
    " In 2015, John Ioannidis, the Stanford professor known for meta-critiques of scientific publishing such as “Why Most Published Research Findings Are False,”
    Ioannidis and other Stanford researchers came out with a new paper arguing that Theranos was not an outlier in failing to publish research vetted by independent experts in scientific journals. (The company eventually published a journal article in 2017 describing its miniLab product.) His team pulled records of publications on 47 healthcare startups that had private valuations over $1 billion, so-called unicorns, to count how many had published peer-reviewed papers about their work and how many of those papers had been cited many times by scientists writing subsequent papers. More citations connotes a paper making a greater impact in its field.

    Without published research, scientists and prospective investors or customers have little to go on to evaluate the marketing claims of a Theranos or other healthcare startups, the Stanford team maintains.
    The 18 companies that were still private at the time of the most recent analysis published 425 scientific papers, of which 34 had been cited by many other papers. The 29 companies that had been acquired or went public had published 413 papers, including 47 highly cited ones.
    https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.13072
    "In 2014, one of us (JPAI) wrote a viewpoint article coining the term “stealth research” for touted biomedical innovation happening outside the peer‐reviewed literature in a confusing mix of “possibly brilliant ideas, aggressive corporate announcements, and mass media hype”."
    Stealth research: lack of peer‐reviewed evidence from healthcare unicorns
    Ioana A. Cristea
    Eli M. Cahan
    John P.A. Ioannidis
    First published: 28 January 2019

    ReplyDelete
  6. Private Equity Stalks Hospitals
    ==================================
    In case you don't recognize it, or for the benefit of younger readers:
    "Private Equity" is the contemporary name for what originated in more generic (genetic) terms where these vulture capitalists operated as:
    Hostile Takeover Specialists.

    Today:
    The next act in healthcare private equity | McKinsey
    www.mckinsey.com/.../the-next-act-in-healthcare-private-equity
    "The next act in healthcare private equity By Clay Bischoff, Brian Fox, and David Quigley. ... Those same factors have propelled the healthcare sector to a leading performance in public markets over the past five years (Exhibit 1). ... (Johnson & Johnson’s oral-health business), accelerated its growth, and eventually sold it. Capturing returns ..."
    --------------
    (Cross Cultural data):
    The Current Investing Landscape: How and Where Managers Are Putting Capital to Work (pdf)
    Global Emerging Markets: Private Equity http://www.leapfroginvest.com/wp-content/uploads/2016/11/Private_Equity_and_Health_Care_in_Emerging_Markets-EMPEA-LEAPFROG.pdf
    --------------
    "The next act in healthcare private equity:"
    HEALTHCARE has led in all sectors in totla returns to Shareholders:
    Buyout firms have taken an increasingly large role in healthcare, investing in the full range of companies: insurers, hospitals, pharmaceutical companies, medical-technology firms, and many kinds of service provider. Historically, success has come from making “smart bets” on companies well positioned to capitalize on an industry trend or shift.
    https://www.mckinsey.com/industries/private-equity-and-principal-investors/our-insights/the-next-act-in-healthcare-private-equity
    ---------------------------------
    This Special note on Mergers applies even more to consolidation under Private Equity :
    "The potential for a monopoly on the market means industry groups and politicians have raised antitrust concerns, asserting that there would be much less competition between national payers as well as a reduction in competition from small-to-medium-sized health insurance companies. Essentially, it would harm other payers attempting to compete in the market."
    https://healthpayerintelligence.com/features/how-health-insurance-mergers-could-change-the-payer-industry
    ---------------------
    Private Equity Stalks Hospitals | Labor Notes
    www.labornotes.org/2013/06/private-equity-stalks-hospitals
    https://www.labornotes.org/2013/06/private-equity-stalks-hospitals
    NYSNA: THE NEW YORK STATE NURSES ASSOCIATION
    Private Equity Stalks Hospitals. English; Español; ... Private equity hospital ownership has a bad track record. Photo: New York State Nurses Association. ... Until today, health care workers had succeeded in keeping LICH “Open for Care,” but they are battling last-minute legislative maneuvers and a threatened Wall Street takeover.
    https://www.labornotes.org/2013/06/private-equity-stalks-hospitals
    Private Equity Stalks Hospitals
    June 20, 2013 / Alexandra Bradbury
    “For-profit health care kills,” said nurse Jill Furillo, executive director of the New York State Nurses Association. “I’ve seen it in other states.”
    Thanks to a boisterous campaign by NYSNA, Service Employees 1199, and community allies, two months ago the state backed off its plan to close LICH. Supporters are now working with SUNY to find a new operator committed to keeping it open.

    But a private equity firm isn’t the kind of new boss they had in mind.
    Private equity’s business model is to borrow large sums, buy up companies, pay off the debt by slashing costs—especially workers’ pay and benefits—and pay out big dividends with what’s left over, then sell off the ruined husk of the company. It’s a ruthless way of making a lot of money fast. (Ironically, a lot of private equity capital comes from union members’ pension funds.)

    ReplyDelete
  7. Defenders of Brooklyn's Long Island College Hospital rallied yesterday against offering it up to Wall Street investors. Private equity hospital ownership has a bad track record. Photo: New York State Nurses Association.
    https://www.labornotes.org/2013/06/private-equity-stalks-hospitals

    ReplyDelete
  8. https://www.commonwealthfund.org/publications/journal-article/2018/nov/pros-cons-public-options-2020-democratic

    Pros and Cons of Different Public Health Insurance Options: A Guide for 2020 Democratic Presidential Candidates November 16, 2018
    Sherry A. Glied and Jeanne M. Lambrew
    Introduction:
    "Options for Expanding Health Care Coverage

    It is more than likely that Democratic candidates for the 2020 presidential election will propose some type of public health insurance plan. In one of two Commonwealth Fund–supported articles in Health Affairs discussing potential Democratic and Republican health care plans for the 2020 election, national health policy experts Sherry Glied and Jeanne Lambrew assess the potential impact and trade-offs of three approaches:

    Incorporating public-plan elements into private plans through mechanisms such as limits on profits, additional rules on how insurers operate, or the use of Medicare payment rates.
    Offering a public plan — some version of Medicare or Medicaid, for example — alongside private plans. Such a plan could be offered to specific age groups, like adults 50 to 64 who are not yet eligible for Medicare, to enrollees in the Affordable Care Act’s (ACA) marketplaces, or to everyone under 65, including those working for self-insured employers. It also could be made available in regions of the country where there is little health care competition.
    Replacing the current health care financing system with a “Medicare for all” single-payer system administered by the federal government. Some single-payer proposals would allow consumers to purchase supplementary private insurance to help pay for uncovered services."

    ReplyDelete
  9. Presidential hopefuls for the 2020 election need to establish their health care reform plans now
    By David Blumenthal January 25, 2019
    https://www.statnews.com/2019/01/25/2020-election-presidential-hopefuls-set-health-care-reform-plans-now/

    "Translating these political truths to 2020 presidential hopefuls means that soon after they announce their candidacies — and maybe even before, as they court donors and key staff —candidates, especially Democrats, will have to commit on health care. Those commitments will set the course for their transitions, their critical early months in office, and what’s likely to emerge from their health care presidencies.

    So, what should we expect as we look ahead to the 2020 election?

    The overwhelming temptation for Democrats will be to embrace “Medicare for all.” It quiets the progressive wing of the party, simplifies our chaotic health system, and achieves Democrats’ long-sought goal — stretching back to Harry Truman — of providing health insurance to all Americans.
    {But....)
    " The politics of health care reform can be as complex as the system itself. But you can take one point to the political bank: Presidents who want to transform the U.S. health system must act quickly after they are elected or re-elected, or they might as well not act at all. And that means the early months of our very long presidential campaign season can be decisive for the future of American health care."
    David Blumenthal, M.D., is president of the Commonwealth Fund and co-author, with James Morone, of “The Heart of Power: Health and Politics in the Oval Office” (University of California Press, 2010).

    ReplyDelete
  10. AND AS IF WE DON'T HAVE ENOUGH TROUBLES....
    RE:
    CORPORATE RAIDING REMIX? FROM RUSSIA WITH LOVE:
    Russian Oil Billionaires' Next Big Investment - American Health Care
    By Irina Reznik
    and Alexander Sazonov
    July 14, 2016, 5:00 PM EDT Updated on July 15, 2016, 4:21 AM EDT
    https://www.bloomberg.com/news/articles/2016-07-14/russian-billionaires-plan-u-s-health-push-with-d-c-insiders

    ReplyDelete

WHO ARE YOU TRYING TO FOOL, NANCY? Will the April 30 Hearing on Medicare For All Be Little More Than a Farce? That may well be the case...